#	Pagina
attuale pagina	/open-h2020/projects/224884/index.html
-1	/open-h2020/per-topic/renewquantum/list/index.html
-2	/open-h2020/per-topic/bluemed/list/index.html
-3	/open-h2020/projects/200825/results.html
-4	/open-h2020/projects/221110/index.html
-5	/open-h2020/projects/220051/index.html
-6	/open-h2020/projects/211445/deliverables.html
-7	/open-h2020/per-topic/adrien/list/index.html
-8	/open-h2020/projects/205625/index.html
-9	/open-h2020/projects/212858/index.html
-10	/open-h2020/per-topic/kwe/list/index.html

Opendata, web and dolomites

LIVELMIA SIGNED

Innovative assay for microRNAs analysis

Total Cost €

EC-Contrib. €

Partnership

Views

LIVELMIA project word cloud

Explore the words cloud of the LIVELMIA project. It provides you a very rough idea of what is the project "LIVELMIA" about.

innovative biological unfortunately strategy customers biomedical health clinic laboratory coming biomarkers profound difficult cancer hospitals generation answer nearly chemical time considerable stakeholders class expensive discovered implicated 4 readings market disruptive ideal helping detect reflected trl6 feasibility segments succeeded of biomolecules alzheimer filed consuming restricting patent move benefits samples cagr 2018 accuracy pricing prototype kit medicine mirnas clinics cells public total 23 mirna therapeutics blood micrornas cut diagnostic forecasted diagnostics newly business human limitations livelmia biopsies intend throughput quantification osteoarthritis prognostic quality diseases submitting ultimate shown gaining dealers plan assay types specificity improvement hours

Project "LIVELMIA" data sheet

The following table provides information about the project.

Coordinator	BIORIDIS SRL Organization address address: VIA ALFONSO RUBBIANI 5 city: BOLOGNA postcode: 40124 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Italy [IT]
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
Code Call	H2020-SMEInst-2018-2020-1
Funding Scheme	SME-1
Starting year	2019
Duration (year-month-day)	from 2019-09-01 to 2020-02-29

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	BIORIDIS SRL BIORIDIS SRL Organization address address: VIA ALFONSO RUBBIANI 5 city: BOLOGNA postcode: 40124 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IT (BOLOGNA)	coordinator	50˙000.00

Map

Project objective

MicroRNAs (miRNAs) are a class of newly discovered biomolecules implicated in numerous biological systems and in common human diseases (e.g. cancer, Alzheimer, osteoarthritis). It has been shown that MiRNAs are biomarkers with great diagnostic and prognostic value. MiRNAs can be the next generation targets for diagnostics and therapeutics and this is reflected in the miRNA analysis market which is forecasted to have a CAGR of 23.4% in the coming years. Unfortunately, miRNAs are very difficult to detect and measure. The methods we have today are complex, expensive and time consuming. These limitations are restricting the use of miRNA in clinics and hospitals for diagnostic medicine. LIVELMIA is an answer to these problems. We has succeeded in developing a disruptive innovative method for high-throughput miRNAs analyses, that allows a general improvement in terms of cost, easy-of-use and accuracy. We have cut down the time required by nearly a factor of 2, bringing the total analysis time down from 6 hours to 3 hours. Furthermore LIVELMIA has a high specificity making it ideal in diagnostics to ensure quality readings in any condition. LIVELMIA is a chemical assay kit for quantification of miRNAs on various types of samples (blood, biopsies, cells) with applications in the field of health research and diagnostics medicine. Our ultimate goal is helping biomedical researchers to improve miRNA studies and move miRNA analysis from laboratory to the clinic to bring profound benefits to public health. Today we have a TRL6/7 prototype. We are gaining considerable interest from potential customers, dealers and stakeholders. We have filed for a patent in 2018 and we are now submitting this Phase 1 proposal in order to study the feasibility and develop a business plan for LIVELMIA, where we intend to study the best segments for exploitation, our pricing strategy, costs, etc.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LIVELMIA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LIVELMIA" are provided by the European Opendata Portal: CORDIS opendata.